4
5
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0932 |
Cefixime
FK-027,头孢克肟,Cefspan,Cefiximum,Cephoral,FR-17027,CL-284635 |
Antibacterial; Antibiotic | Microbiology/Virology |
Cefixime (FR-17027) 是一种头孢菌素类抗生素, 可研究一些细菌感染。 | |||
T38643 |
Cefixime trihydrate
CL-284635trihydrate,FR-17027 trihydrate,FK-027trihydrate |
||
Cefixime trihydrate (FR-17027 trihydrate) is a potent antibiotic belonging to the third generation of cephalosporins. Its efficacy lies in the treatment of various bacterial infections. | |||
T82616 |
Dalcinonacog alfa
CB-2679d,ISU-304,DalcA |
||
Dalcinonacog alfa为重组FIX因子,用于血友病B的科研之用。 | |||
T77124 |
Osocimab
BAY 1213790 |
FXR | Metabolism |
Osocimab (BAY 1213790) 是一种高效的抗 FXIa 抗体,Ki 值为 2.4 nM,EC50 值为 0.2 nM。Osocimab 可能通过 FXI 抑制降低血栓形成。Osocimab 常被当作 XI 因子抑制剂,对凝血酶生成有抑制作用,有抗凝血作用,可用于研究血栓栓塞性疾病。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-02215 |
Coagulation factor IX/F9 Protein, Human, Recombinant (His)
FIX,PTC,Coagulation factor 9,coagulation factor IX,... |
Human | HEK293 Cells |
Coagulation factor IX/F9 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 50 kDa and the accession number is AAB59620.1. | |||
TMPY-05355 |
Coagulation factor IX/F9 Protein, Human, Recombinant (hFc)
P19,Coagulation factor 9,HEMB,FIX,THPH8,Coagulation... |
Human | HEK293 Cells |
Coagulation factor IX/F9 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 75.5 kDa and the accession number is P00740-1. | |||
TMPY-01104 |
Coagulation factor XI/F11 Protein, Human, Recombinant (His)
coagulation factor 11,coagulation factor XI,FXI |
Human | HEK293 Cells |
Factor XI (plasma thromboplastin antecedent) is a plasma glycoprotein, and a zymogen acting as a serine protease which participates in blood coagulation as a catalyst in the conversion of factor IX to factor IXa in the presence of calcium ions. It is an unusual dimeric protease, with structural features that distinguish it from vitamin K-dependent coagulation proteases. The factor XI is synthesized in the liver as a single polypeptide chain with a molecular weight estimated between 125 ~160 kDa ... | |||
TMPK-01271 |
Coagulation factor XI Protein, Cynomolgus, Recombinant (His)
F11,PTA,FXI,Coagulation factor XI |
Cynomolgus | HEK293 Cells |
Factor XI (FXI) is the zymogen of a plasma protease (FXIa) that contributes to hemostasis by activating factor IX (FIX). In the original cascade model of coagulation, FXI is converted to FXIa by factor XIIa (FXIIa), a component, along with prekallikrein and high-molecular-weight kininogen (HK), of the plasma kallikrein-kinin system (KKS). | |||
TMPY-02014 |
Coagulation factor VII/F7 Protein, Human, Recombinant (His)
coagulation factor VII (serum prothrombin conversion acceler... |
Human | HEK293 Cells |
Coagulation factor VII, also known as Serum prothrombin conversion accelerator, Factor VII, F7 and FVII, is a member of the peptidase S1 family. Factor VII is one of the central proteins in the coagulation cascade. It is an enzyme of the serine protease class, and Factor VII (FVII) deficiency is the most frequent among rare congenital bleeding disorders. Factor VII contains two EGF-like domains, one Gla (gamma-carboxy-glutamate) domain and one peptidase S1 domain. The main role of factor VII is ... |